The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.


Updates from The Motley Fool

Latest updates on DaVita from Fool.com.  The Fool has written over 100 articles on DaVita.
Today's 3 Best Stocks

A roundup of the day's best performers within the S&P 500 and what their moves mean for investors.



Stock Performance

View Interactive DVA Charts
Sponsored by

Key Data Points

Primary metrics and data points about DaVita.
Current Price: $68.81
Prev Close: $69.19
Open: $69.00
Bid: $67.98
Ask: $69.77
Day's Range: $68.70 - $69.27
52wk Range: $54.50 - $78.77
Volume: 753,258
Avg Vol 1,379,187
Market Cap: $13B
P/E (ttm): 16.09
EPS (ttm): $4.38
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about DaVita.
CAPS Rating 5 out of 5
 
408 Outperform
17 Underperform
CAPS All Stars
 
96 Outperform
4 Underperform

How do you think DaVita will perform against the market?



You pick for DaVita is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kent J. Thiry, CEO

82% Approve

Based on 854 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for DaVita.

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Healthcare IT